The themes Intelligent Bio Solutions is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from Intelligent Bio Solutions Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$2.05-8.7%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed November 10, 2026
Company outlook: revenue of about $1.4M for Fiscal Q1 2027 — up 25.0% on a year earlier, slower than the 35.8% just reported
Just reported
From Intelligent Bio Solutions's results release of November 10, 2026; its quarterly report has since been filed.
Actual
$1.4M
+25% y/y
+21% q/q
Guided
—
No guide given
Actual
-$0.86
Guided
—
No guide given
Actual
-$2.7M
Guided
—
No guide given
Q1 FY2027
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade F-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 21 quarters of Intelligent Bio Solutions Inc.’s grade history. The other 19 go back to November 2021.